Moderna says it will file Monday for emergency approval of its coronavirus vaccine
The company is just one of three that has a vaccine on the verge of federal approval that could lead to vaccinations in the U.S. in the coming weeks or months.
Moderna said Monday that the biotechnology company will file for emergency approval of its coronavirus vaccine. The company says its vaccine has shown 94% effectiveness in late-stage clinical trials.
The company is just one of three that has a vaccine that has recently shown at least 90% effectiveness.
American pharmaceutical company Pfizer and German firm BioTech are also seeking FDA approval that could come as early as next month. Astra Zeneca recently said its vaccine was 90% effective in recent clinical trials.
Just News, No Noise
- New twist in FBI raid: Trump had 'standing order' to declassify documents taken to residence
- Marjorie Taylor Greene files articles of impeachment against Merrick Garland
- Top Democrat Clyburn: $740 billion spending-tax bill will be issue in midterm elections
- Arizona’s U.S. Senate seat rated a toss-up by election forecasters
- Two Democratic lawmakers cast 10 proxy votes each on House floor in favor of $740B spending bill